Skip to main content

Nonprofit · EIN 47-3108868

TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION

Also known as TESS FOUNDATION

Tax-exempt · MENLO PARK, CA 94026

Financials

$504K$498K2023$542K$584K2024
Revenue Expenses · by fiscal year end
Financials of TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$541,973$584,239-$42,266$407,310$1,651$405,659
December 31, 2023990$503,647$497,687$5,960$459,776$11,812$447,964
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$581,056
Program service revenue
$0
Investment income
$1,036
Net income from fundraising events
-$40,330
Other revenue
-$40,119

Expenses

Grants and similar amounts paid
$174,093
Compensation of officers, directors and key employees
$67,838
Other salaries and wages
$175,688
Salaries, compensation and benefits (total)
$267,681
Professional fundraising fees
$0
Accounting fees
$5,701
Travel
$14,804
Program services (functional)
$515,458
Management and general (functional)
$13,473
Fundraising (functional)
$55,308

Balance sheet and other

Total assets, start of year
$459,776
Total assets, end of year
$407,310
Total liabilities, end of year
$1,651
Net assets, end of year
$405,659
Net assets without donor restrictions
$405,659
Gross receipts
$582,303
Employees
2
Volunteers
50
Year formed
2015
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
Amber BlackSecretary
Trustee or director, Officer
40$67,838
Paula GaniDirector
Trustee or director
3$0
Courtney AlbertiDirector
Trustee or director
2$0
Adam AlbertiDirector
Trustee or director
2$0
Lee ScheuerDirector
Trustee or director
3$0
Robert WassmanDirector
Trustee or director
3$0
Don NeaultDirector
Trustee or director
3$0
Janet WojcickiDirector
Trustee or director
3$0
Megan GilbertDirector
Trustee or director
3$0
Rich WindischDirector
Trustee or director
3$0
Kimberly NyeChair & Executive Director
Trustee or director, Officer
40$0
Kevin McDonnellTreasurer
Trustee or director, Officer
3$0
Michael BlackVice Chair
Trustee or director, Officer
5$0
990 for the year ended December 31, 2023: 9 people
NameTitleHours / weekCompensation
Adam AlbertiDirector
Trustee or director
2$0
Lee ScheuerDirector
Trustee or director
3$0
Robert WassmanDirector
Trustee or director
3$0
Courtney AlbertiDirector
Trustee or director
2$0
Kimberly NyeChair & Executive Director
Trustee or director, Officer
40$0
Michael BlackVice Chair as of 51
Trustee or director, Officer
5$0
Paula GaniSecretary
Trustee or director, Officer
5$0
Kevin McDonnellTreasurer
Trustee or director, Officer
3$0
Amber BlackVice Chair until 430
Trustee or director, Officer
5$0

Address and contacts

Address (IRS master file)
655 OAK GROVE AVE UNIT 53, MENLO PARK, CA 94026-5000
In care of
% KIMBERLY NYE
Principal officer (990 for 2024)
Kimberly Nye, 430 Claremont Way, Menlo Park, CA 94025
Signed the 990
KIMBERLY NYE, Chair & Executive Director
Phone
(650) 521-2279
Return prepared by
Mullins PC

California records

California keeps its own records of charities and corporations. Search them by EIN 47-3108868 or by the name TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

Tess Research Foundations goal is to find better treatment options for SLC13A5 deficiency, (Continued on Sch O)

990 for the year ended December 31, 2024

Program accomplishments

  • Funding Scientific Research - We continued our in-person, digital and remote natural history studies for SLC13A5 with Brown University, UT Southwestern, and Stanford University. These studies are key for our clinical trial readiness. We also funded basic and translational research.
    Expenses $281,706
  • Education, Family Support and Awareness - We are the only organization dedicated to supporting families with SLC13A5 Epilepsy and raising awareness about the disease. Our ongoing program includes sharing updates about the latest research findings and connecting and empowering families so they can share their experiences and support one another. We have an annual awareness day (May 13), host monthly virtual support calls, maintain a website, and send a monthly electronic newsletter.
    Expenses $132,924
  • Conference - We continue to create a patient-centered network of doctors, researchers, clinicians, and families. TESS hosted the largest-ever SLC13A5 family and professional conference in Providence, Rhode Island. We attend neurology, epilepsy, and drug development conferences.
    Expenses $100,828

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
47-3108868
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2015
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H12)
Assets (IRS master file)
$407,310
Income (IRS master file)
$582,303

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$541,973$584,239$407,310IRS
990December 2023$503,647$497,687$459,776XML
990December 2022$610,734$868,351$447,207IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 47-3108868).

Questions about TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION

What is the EIN of TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION?
The employer identification number (EIN) of TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION is 47-3108868.
Is TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2015.
Are donations to TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION?
The 990 for the year ended December 31, 2024 names Kimberly Nye.
Who are the officers and directors of TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION?
The 990 for the year ended December 31, 2024 lists 13 people; 1 received compensation from the organization, the highest $67,838 (Amber Black, Secretary).
How much revenue does TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $541,973, expenses of $584,239 and total assets of $407,310 at year end.

Other nonprofits in MENLO PARK

All nonprofits in MENLO PARK · California · Medical research